<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005305'>Cerebral venous thrombosis</z:hpo> (CVT) is a serious condition affecting mostly women </plain></SENT>
<SENT sid="1" pm="."><plain>This report concerns two cases of women who developed CVT within 14 days of cesarean delivery </plain></SENT>
<SENT sid="2" pm="."><plain>Magnetic resonance angiography of the brain (venous phase) is the best modality to diagnose the condition, and parenteral application of low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi> is the most beneficial treatment </plain></SENT>
<SENT sid="3" pm="."><plain>The first patient was found to have an elevated factor VIII level </plain></SENT>
<SENT sid="4" pm="."><plain>In the second patient, homozygosity of the C677T mutation in the <z:chebi fb="0" ids="12071">5,10-methylenetetrahydrofolate</z:chebi> reductase gene was found </plain></SENT>
<SENT sid="5" pm="."><plain>The puerperal period and Cesarean Section (CS) are risk factors for thrombotic complications, including CVT </plain></SENT>
<SENT sid="6" pm="."><plain>It is necessary to search for risk factors in a patient's history and within the group of at-risk patients to prolong preventive administration of low molecular weight <z:chebi fb="5" ids="28304">heparin</z:chebi> (LMWH) </plain></SENT>
<SENT sid="7" pm="."><plain>CVT (including puerperium related) is not a detrimental to future pregnancies </plain></SENT>
</text></document>